syndrome characterized by central nervous system dysfunction in association with liver failure, including portal-systemic shunts; clinical features include lethargy and confusion, frequently progressing to coma, asterixis, nystagmus, brisk oculovestibular reflexes, decorticate and decerebrate posturing, muscle spasticity, and bilateral extensor plantar reflexes.

Literature | 10,846 results

View All

• Hepatic encephalopathy and fitness to drive.

  Authors: Gerald Kircheis, Anja Knoche, Norbert Hilger, Frank Manhart, Alfons Schnitzler, Horst Schulze, Dieter Häussinger

  Gastroenterology 2009 Nov

• Inhibitory control test for the diagnosis of minimal hepatic encephalopathy.

  Authors: Jasmohan S Bajaj, Muhammad Hafeezullah, Jose Franco, Rajiv R Varma, Raymond G Hoffmann, Joshua F Knox, Darrell Hischke, Thomas A Hammeke, Steven D Pinkerton, Kia Saeian

  Gastroenterology 2008 Nov

Associated Researchers

Thought leaders and organizations working on research involving hepatic encephalopathy.

View All Authors

• Blanca Piedrafita
• Vicente Felipo
• William M Lee
• Karin Weissenborn
• Marta Llansola

View All Clinical Trials Sponsors

• Salix Pharmaceuticals
• Hunter Holmes Mcguire Veteran Affairs Medical Center
• Aga Khan University
• Ocera Therapeutics
• Hospital Universitari Vall d'Hebron Research Institute

View All Organizations

• Virginia Commonwealth University and McGuire VA Medical Center
• G. B. Pant Hospital
• Heinrich-Heine-University Düsseldorf
• Centro de Investigación Príncipe Felipe
• Hadassah-Hebrew University Medical School

Clinical Trials | 522 trials

View All

• A 6-Month Efficacy, Safety and Tolerability Study of Rifaximin In Preventing Hepatic Encephalopathy

  conditions: Hepatic Encephalopathy

  interventions: Rifaximin

   

• RICE Trial: Rifaximin In Chronic Hepatic Encephalopathy - A Randomized, Controlled Trial

  conditions: Hepatic Encephalopathy

  interventions: Rifaximin alone, Rifaximin combined with Lactulose

   

News | 10 stories

View All

• Health Matters : What is Hepatic Encephalopathy ?

  PR-inside.com. - November 06, 2009

• Enrollment complete in Ocera Therapeutics' ASTUTE Phase 2B trial for mild hepatic encephalopathy

  News-Medical. - February 23, 2010

Community

NextBio Users

• No NextBio users were found for “hepatic encephalopathy”.
  Complete your user profile with your interests, if you want others to find you within the NextBio community.

NextBio Groups

• No NextBio groups were found for “hepatic encephalopathy”.
  Be the first to start a group and share your interests with others within the NextBio community.

search → result

search → result